Surgical biology for the clinician: vascular effects of immunosuppression.
作者信息
Tepperman Elissa, Ramzy Danny, Prodger Jessica, Sheshgiri Rohit, Badiwala Mitesh, Ross Heather, Raoa Vivek
机构信息
Division of Cardiovascular Surgery, University Health Network, Toronto, Ont.
出版信息
Can J Surg. 2010 Feb;53(1):57-63.
Abstract
摘要
相似文献
1
Surgical biology for the clinician: vascular effects of immunosuppression.临床医生的外科生物学：免疫抑制的血管效应
Can J Surg. 2010 Feb;53(1):57-63.
2
Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.心脏移植受者的药物治疗：第二部分：免疫抑制药物
Circulation. 2004 Dec 21;110(25):3858-65. doi: 10.1161/01.CIR.0000150332.42276.69.
3
[Pro- and antitumor effects of the main immunosuppressive drugs used in the clinical practice of transplantation].[移植临床实践中使用的主要免疫抑制药物的促肿瘤和抗肿瘤作用]
G Ital Nefrol. 2007 Mar-Apr;24(2):171.
4
Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis.mTOR 抑制剂西罗莫司和依维莫司具有很强的抗纤维化活性，但环孢素 A 和他克莫司则没有这种活性，在实验性肝纤维化中。
J Hepatol. 2011 Aug;55(2):388-98. doi: 10.1016/j.jhep.2010.10.044. Epub 2010 Dec 17.
5
Immunosuppressive drugs and the induction of transplantation tolerance.
Transpl Immunol. 1994 Dec;2(4):263-70. doi: 10.1016/0966-3274(94)90001-9.
6
Current State of Immunosuppression: Past, Present, and Future.免疫抑制的现状：过去、现在与未来
Crit Rev Eukaryot Gene Expr. 2015;25(2):113-34. doi: 10.1615/critreveukaryotgeneexpr.2015011421.
7
Everolimus: a proliferation signal inhibitor targeting primary causes of allograft dysfunction.依维莫司：一种针对同种异体移植功能障碍主要病因的增殖信号抑制剂。
Drugs Today (Barc). 2004 Feb;40(2):101-9. doi: 10.1358/dot.2004.40.2.799422.
8
Effects of immunosuppressive therapy on wound healing.免疫抑制疗法对伤口愈合的影响。
Int Wound J. 2013 Feb;10(1):98-104. doi: 10.1111/j.1742-481X.2012.00950.x. Epub 2012 Feb 24.
9
Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions.在非清髓性条件下，钙调神经磷酸酶抑制剂或西罗莫司与抗CD40L单克隆抗体对同种异体移植的联合作用。
Blood. 2002 Nov 1;100(9):3400-7. doi: 10.1182/blood-2002-03-0872.
10
Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial.他克莫司联合霉酚酸酯与环孢素联合依维莫司治疗尸肾移植受者：一项单中心前瞻性临床试验 3 年结果。
Clin Transplant. 2013 Jul-Aug;27(4):E359-67. doi: 10.1111/ctr.12141. Epub 2013 May 26.
引用本文的文献
1
Beneficial effects of rapamycin on endothelial function in systemic lupus erythematosus.雷帕霉素对系统性红斑狼疮患者内皮功能的有益作用。
Front Physiol. 2024 Aug 21;15:1446836. doi: 10.3389/fphys.2024.1446836. eCollection 2024.
2
Rapidly Growing and Ruptured Great Saphenous Vein Aneurysm in a Liver Transplant Patient.肝移植患者中快速生长并破裂的大隐静脉动脉瘤。
Medicina (Kaunas). 2024 Feb 8;60(2):290. doi: 10.3390/medicina60020290.
3
Impact of Exercise Modalities on Peripheral and Central Components of Cardiorespiratory Capacity in Heart Transplantation Patients: A Systematic Review and Meta-Analysis.运动方式对心脏移植患者心肺能力外周和中枢组分的影响：系统评价和荟萃分析。
Medicina (Kaunas). 2021 Dec 24;58(1):32. doi: 10.3390/medicina58010032.
4
Combined abdominal heterotopic heart and aorta transplant model in mice.小鼠腹部异位心脏和主动脉联合移植模型。
PLoS One. 2020 Jun 22;15(6):e0230649. doi: 10.1371/journal.pone.0230649. eCollection 2020.
5
Immunosuppressive protocols with tacrolimus after cryopreserved aortal allotransplantation in rats.大鼠冷冻保存主动脉同种异体移植后使用他克莫司的免疫抑制方案。
PLoS One. 2018 Aug 9;13(8):e0201984. doi: 10.1371/journal.pone.0201984. eCollection 2018.
6
The clinical characteristics of posterior reversible encephalopathy syndrome in patients with chronic renal failure.慢性肾功能衰竭患者后可逆性脑病综合征的临床特征
Exp Ther Med. 2017 Jul;14(1):881-887. doi: 10.3892/etm.2017.4570. Epub 2017 Jun 8.
7
Cyclosporine Does Not Prevent Microvascular Loss in Transplantation but Can Synergize With a Neutrophil Elastase Inhibitor, Elafin, to Maintain Graft Perfusion During Acute Rejection.环孢素不能预防移植中的微血管丢失，但可与中性粒细胞弹性蛋白酶抑制剂弹性蛋白协同作用，在急性排斥反应期间维持移植物灌注。
Am J Transplant. 2015 Jul;15(7):1768-81. doi: 10.1111/ajt.13189. Epub 2015 Feb 27.
8
Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension.炎症、氧化应激和血管功能障碍在高血压中的作用。
Biomed Res Int. 2014;2014:406960. doi: 10.1155/2014/406960. Epub 2014 Jul 20.
9
Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients.依维莫司免疫抑制可降低肝移植受者血清中纤维化标志物的表达。
World J Transplant. 2014 Jun 24;4(2):133-40. doi: 10.5500/wjt.v4.i2.133.
10
Graft microvascular disease in solid organ transplantation.实体器官移植中的移植物微血管疾病
J Mol Med (Berl). 2014 Aug;92(8):797-810. doi: 10.1007/s00109-014-1173-y. Epub 2014 Jun 1.
本文引用的文献
1
Effects of cyclosporine, tacrolimus and sirolimus on vascular changes related to immune response.环孢素、他克莫司和西罗莫司对与免疫反应相关的血管变化的影响。
J Heart Lung Transplant. 2008 Apr;27(4):416-22. doi: 10.1016/j.healun.2008.01.006.
2
UNOS Liver Registry: ten year survivals.器官共享联合网络肝脏登记处：十年生存率
Clin Transpl. 2006:29-39.
3
Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.实体器官移植中减少钙调神经磷酸酶抑制剂的方案：关注改善肾功能和肾毒性。
Clin Transplant. 2008 Jan-Feb;22(1):1-15. doi: 10.1111/j.1399-0012.2007.00739.x.
4
Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007.国际心肺移植学会登记处：2007年第24份成人肺与心肺移植官方报告
J Heart Lung Transplant. 2007 Aug;26(8):782-95. doi: 10.1016/j.healun.2007.06.003.
5
Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007.国际心肺移植学会登记处：2007年第24份成人心脏移植官方报告
J Heart Lung Transplant. 2007 Aug;26(8):769-81. doi: 10.1016/j.healun.2007.06.004.
6
Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine.内皮素-1和一氧化氮生物利用度在移植相关血管损伤中的作用：雷帕霉素和环孢素的比较效应
Circulation. 2006 Jul 4;114(1 Suppl):I214-9. doi: 10.1161/CIRCULATIONAHA.105.000471.
7
mTOR inhibition induces endothelial progenitor cell death.
Am J Transplant. 2006 Sep;6(9):2069-79. doi: 10.1111/j.1600-6143.2006.01433.x. Epub 2006 Jun 22.
8
Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients--a large European trial.他克莫司对比环孢素在心脏移植受者中对急性排斥反应的卓越预防效果——一项大型欧洲试验
Am J Transplant. 2006 Jun;6(6):1387-97. doi: 10.1111/j.1600-6143.2006.01300.x.
9
Coronary endothelial vasomotor function and vascular remodeling in heart transplant recipients randomized for tacrolimus or cyclosporine immunosuppression.
J Am Coll Cardiol. 2006 Apr 18;47(8):1622-9. doi: 10.1016/j.jacc.2005.10.073. Epub 2006 Mar 27.
10
Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.一项关于他克莫司与微乳环孢素用于心脏移植患者的随机单中心研究的五年结果
J Heart Lung Transplant. 2006 Apr;25(4):434-9. doi: 10.1016/j.healun.2005.11.452. Epub 2006 Feb 17.
Zotero 插件